Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CNOT4 | Human | 1,2-dichloroethane | decreases expression | ISO | Cnot4 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of CNOT4 mRNA | CTD | PMID:28960355 | CNOT4 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Cnot4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CNOT4 mRNA | CTD | PMID:22206623 | CNOT4 | Human | 17alpha-ethynylestradiol | affects expression | ISO | Cnot4 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of CNOT4 mRNA | CTD | PMID:17555576 | CNOT4 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of CNOT4 mRNA | CTD | PMID:16467188 more ... | CNOT4 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of CNOT4 mRNA | CTD | PMID:19400957 | CNOT4 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Cnot4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNOT4 mRNA | CTD | PMID:17942748 | CNOT4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cnot4 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CNOT4 mRNA | CTD | PMID:17942748 | CNOT4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CNOT4 mRNA | CTD | PMID:32109520 and PMID:33387578 | CNOT4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cnot4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CNOT4 mRNA | CTD | PMID:21570461 | CNOT4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CNOT4 mRNA | CTD | PMID:22298810 | CNOT4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CNOT4 mRNA | CTD | PMID:17942748 | CNOT4 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CNOT4 mRNA | CTD | PMID:21179406 | CNOT4 | Human | 3,4-methylenedioxymethamphetamine | increases methylation | ISO | Cnot4 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of CNOT4 promoter | CTD | PMID:26251327 | CNOT4 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Cnot4 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CNOT4 mRNA | CTD | PMID:26251327 | CNOT4 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CNOT4 mRNA | CTD | PMID:28628672 | CNOT4 | Human | 4-amino-2,6-dinitrotoluene | affects expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of CNOT4 mRNA | CTD | PMID:21346803 | CNOT4 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Fenretinide results in increased expression of CNOT4 mRNA | CTD | PMID:28973697 | CNOT4 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of CNOT4 gene | CTD | PMID:27153756 | CNOT4 | Human | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of CNOT4 intron | CTD | PMID:30157460 | CNOT4 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of CNOT4 mRNA | CTD | PMID:33212167 | CNOT4 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CNOT4 mRNA | CTD | PMID:17879257 | CNOT4 | Human | benzo[a]pyrene | increases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CNOT4 mRNA | CTD | PMID:22228805 | CNOT4 | Human | benzo[a]pyrene | decreases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CNOT4 mRNA | CTD | PMID:19770486 | CNOT4 | Human | bisphenol A | decreases expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CNOT4 mRNA | CTD | PMID:25181051 | CNOT4 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CNOT4 mRNA | CTD | PMID:28628672 | CNOT4 | Human | C60 fullerene | increases expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | fullerene C60 results in increased expression of CNOT4 mRNA | CTD | PMID:19167457 | CNOT4 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT4 mRNA | CTD | PMID:35301059 | CNOT4 | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of CNOT4 mRNA and Cadmium Chloride results in increased expression of CNOT4 protein | CTD | PMID:26472689 and PMID:38185225 | CNOT4 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT4 mRNA | CTD | PMID:35301059 | CNOT4 | Human | carbon nanotube | decreases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of CNOT4 mRNA | CTD | PMID:25554681 | CNOT4 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CNOT4 gene] | CTD | PMID:28238834 | CNOT4 | Human | chlorpyrifos | decreases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CNOT4 mRNA | CTD | PMID:20350560 | CNOT4 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CNOT4 mRNA | CTD | PMID:28628672 | CNOT4 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of CNOT4 mRNA | CTD | PMID:37042841 | CNOT4 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of CNOT4 mRNA | CTD | PMID:28302478 | CNOT4 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CNOT4 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CNOT4 mRNA | CTD | PMID:29803840 | CNOT4 | Human | fenofibrate | multiple interactions | ISO | Cnot4 (Mus musculus) | 6480464 | PPARA protein affects the reaction [Fenofibrate results in increased expression of CNOT4 mRNA] | CTD | PMID:21318169 | CNOT4 | Human | fenofibrate | increases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Fenofibrate results in increased expression of CNOT4 mRNA | CTD | PMID:21318169 | CNOT4 | Human | fenthion | increases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Fenthion results in increased expression of CNOT4 mRNA | CTD | PMID:34813904 | CNOT4 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of CNOT4 mRNA | CTD | PMID:20655997 | CNOT4 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of CNOT4 protein | CTD | PMID:37730182 | CNOT4 | Human | gentamycin | increases expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CNOT4 mRNA | CTD | PMID:33387578 | CNOT4 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CNOT4 mRNA | CTD | PMID:28628672 | CNOT4 | Human | mercury dibromide | decreases expression | EXP | | 6480464 | mercuric bromide results in decreased expression of CNOT4 mRNA | CTD | PMID:26272509 | CNOT4 | Human | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT4 mRNA | CTD | PMID:27188386 | CNOT4 | Human | methidathion | increases expression | ISO | Cnot4 (Mus musculus) | 6480464 | methidathion results in increased expression of CNOT4 mRNA | CTD | PMID:34813904 | CNOT4 | Human | methoxychlor | affects methylation | ISO | Cnot4 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of CNOT4 gene | CTD | PMID:35440735 | CNOT4 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of CNOT4 mRNA | CTD | PMID:28001369 | CNOT4 | Human | oxaliplatin | multiple interactions | ISO | Cnot4 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CNOT4 mRNA | CTD | PMID:25729387 | CNOT4 | Human | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT4 mRNA | CTD | PMID:27188386 | CNOT4 | Human | paracetamol | increases expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of CNOT4 mRNA | CTD | PMID:33387578 | CNOT4 | Human | pentanal | decreases expression | EXP | | 6480464 | pentanal results in decreased expression of CNOT4 mRNA | CTD | PMID:26079696 | CNOT4 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of CNOT4 mRNA | CTD | PMID:26272509 | CNOT4 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT4 mRNA | CTD | PMID:27188386 | CNOT4 | Human | Salinomycin | decreases expression | EXP | | 6480464 | salinomycin results in decreased expression of CNOT4 mRNA | CTD | PMID:19682730 | CNOT4 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CNOT4 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of CNOT4 mRNA | CTD | PMID:25895662 | CNOT4 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of CNOT4 mRNA | CTD | PMID:38568856 | CNOT4 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | sodium arsenite promotes the reaction [CNOT4 protein binds to CAPRIN1 protein] | CTD | PMID:33939924 | CNOT4 | Human | succimer | multiple interactions | ISO | Cnot4 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CNOT4 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CNOT4 mRNA | CTD | PMID:21641980 and PMID:26378955 | CNOT4 | Human | tamoxifen | increases expression | ISO | Cnot4 (Mus musculus) | 6480464 | Tamoxifen results in increased expression of CNOT4 mRNA | CTD | PMID:19400957 | CNOT4 | Human | tamoxifen | affects expression | ISO | Cnot4 (Mus musculus) | 6480464 | Tamoxifen affects the expression of CNOT4 mRNA | CTD | PMID:17555576 | CNOT4 | Human | tamoxifen | increases expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | Tamoxifen results in increased expression of CNOT4 mRNA | CTD | PMID:19400957 | CNOT4 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of CNOT4 mRNA | CTD | PMID:33359661 | CNOT4 | Human | testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of CNOT4 mRNA | CTD | PMID:17440010 | CNOT4 | Human | thiram | increases expression | EXP | | 6480464 | Thiram results in increased expression of CNOT4 mRNA | CTD | PMID:38568856 | CNOT4 | Human | titanium dioxide | increases methylation | ISO | Cnot4 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of CNOT4 gene and titanium dioxide results in increased methylation of CNOT4 promoter | CTD | PMID:35295148 | CNOT4 | Human | topotecan | multiple interactions | ISO | Cnot4 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CNOT4 mRNA | CTD | PMID:25729387 | CNOT4 | Human | topotecan | decreases expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of CNOT4 mRNA | CTD | PMID:25729387 | CNOT4 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of CNOT4 mRNA | CTD | PMID:24935251 and PMID:26272509 | CNOT4 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT4 mRNA | CTD | PMID:27188386 | CNOT4 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of CNOT4 mRNA | CTD | PMID:37042841 | CNOT4 | Human | triptonide | increases expression | ISO | Cnot4 (Mus musculus) | 6480464 | triptonide results in increased expression of CNOT4 mRNA | CTD | PMID:33045310 | CNOT4 | Human | troglitazone | decreases expression | ISO | Cnot4 (Mus musculus) | 6480464 | troglitazone results in decreased expression of CNOT4 mRNA | CTD | PMID:28973697 | CNOT4 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of CNOT4 mRNA | CTD | PMID:28818685 | CNOT4 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CNOT4 mRNA | CTD | PMID:23179753 more ... | CNOT4 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT4 mRNA | CTD | PMID:27188386 | CNOT4 | Human | vinclozolin | increases expression | ISO | Cnot4 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of CNOT4 mRNA | CTD | PMID:23034163 | |